39 related articles for article (PubMed ID: 23729015)
1. Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations.
Jaffrain-Rea ML; Rotondi S; Turchi A; Occhi G; Barlier A; Peverelli E; Rostomyan L; Defilles C; Angelini M; Oliva MA; Ceccato F; Maiorani O; Daly AF; Esposito V; Buttarelli F; Figarella-Branger D; Giangaspero F; Spada A; Scaroni C; Alesse E; Beckers A
Endocr Relat Cancer; 2013 Oct; 20(5):753-66. PubMed ID: 23940012
[TBL] [Abstract][Full Text] [Related]
2. A clinically novel AIP mutation in a patient with a very large, apparently sporadic somatotrope adenoma.
Salvatori R; Daly AF; Quinones-Hinojosa A; Thiry A; Beckers A
Endocrinol Diabetes Metab Case Rep; 2014; 2014():140048. PubMed ID: 25136448
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy and safety of pegvisomant in combination with long-acting somatostatin analogs in acromegaly.
Neggers SJ; Franck SE; de Rooij FW; Dallenga AH; Poublon RM; Feelders RA; Janssen JA; Buchfelder M; Hofland LJ; Jørgensen JO; van der Lely AJ
J Clin Endocrinol Metab; 2014 Oct; 99(10):3644-52. PubMed ID: 24937542
[TBL] [Abstract][Full Text] [Related]
4. Expert consensus document: A consensus on the medical treatment of acromegaly.
Giustina A; Chanson P; Kleinberg D; Bronstein MD; Clemmons DR; Klibanski A; van der Lely AJ; Strasburger CJ; Lamberts SW; Ho KK; Casanueva FF; Melmed S;
Nat Rev Endocrinol; 2014 Apr; 10(4):243-8. PubMed ID: 24566817
[TBL] [Abstract][Full Text] [Related]
5. The 3PAs: An Update on the Association of Pheochromocytomas, Paragangliomas, and Pituitary Tumors.
Xekouki P; Brennand A; Whitelaw B; Pacak K; Stratakis CA
Horm Metab Res; 2019 Jul; 51(7):419-436. PubMed ID: 30273935
[TBL] [Abstract][Full Text] [Related]
6. Pituitary adenoma with paraganglioma/pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and mice.
Xekouki P; Szarek E; Bullova P; Giubellino A; Quezado M; Mastroyannis SA; Mastorakos P; Wassif CA; Raygada M; Rentia N; Dye L; Cougnoux A; Koziol D; Sierra Mde L; Lyssikatos C; Belyavskaya E; Malchoff C; Moline J; Eng C; Maher LJ; Pacak K; Lodish M; Stratakis CA
J Clin Endocrinol Metab; 2015 May; 100(5):E710-9. PubMed ID: 25695889
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort.
Dénes J; Swords F; Rattenberry E; Stals K; Owens M; Cranston T; Xekouki P; Moran L; Kumar A; Wassif C; Fersht N; Baldeweg SE; Morris D; Lightman S; Agha A; Rees A; Grieve J; Powell M; Boguszewski CL; Dutta P; Thakker RV; Srirangalingam U; Thompson CJ; Druce M; Higham C; Davis J; Eeles R; Stevenson M; O'Sullivan B; Taniere P; Skordilis K; Gabrovska P; Barlier A; Webb SM; Aulinas A; Drake WM; Bevan JS; Preda C; Dalantaeva N; Ribeiro-Oliveira A; Garcia IT; Yordanova G; Iotova V; Evanson J; Grossman AB; Trouillas J; Ellard S; Stratakis CA; Maher ER; Roncaroli F; Korbonits M
J Clin Endocrinol Metab; 2015 Mar; 100(3):E531-41. PubMed ID: 25494863
[TBL] [Abstract][Full Text] [Related]
8. Succinate dehydrogenase deficiency is rare in pituitary adenomas.
Gill AJ; Toon CW; Clarkson A; Sioson L; Chou A; Winship I; Robinson BG; Benn DE; Clifton-Bligh RJ; Dwight T
Am J Surg Pathol; 2014 Apr; 38(4):560-6. PubMed ID: 24625421
[TBL] [Abstract][Full Text] [Related]
9. The adrenal medulla and extra-adrenal paraganglia: then and now.
Tischler AS; Pacak K; Eisenhofer G
Endocr Pathol; 2014 Mar; 25(1):49-58. PubMed ID: 24362581
[TBL] [Abstract][Full Text] [Related]
10. 15 YEARS OF PARAGANGLIOMA: The association of pituitary adenomas and phaeochromocytomas or paragangliomas.
O'Toole SM; Dénes J; Robledo M; Stratakis CA; Korbonits M
Endocr Relat Cancer; 2015 Aug; 22(4):T105-22. PubMed ID: 26113600
[TBL] [Abstract][Full Text] [Related]
11. 15 YEARS OF PARAGANGLIOMA: Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations.
Baysal BE; Maher ER
Endocr Relat Cancer; 2015 Aug; 22(4):T71-82. PubMed ID: 26113606
[TBL] [Abstract][Full Text] [Related]
12. Means, motive, and opportunity: SDH mutations are suspects in pituitary tumors.
Beckers A
J Clin Endocrinol Metab; 2013 Jun; 98(6):2274-6. PubMed ID: 23729015
[No Abstract] [Full Text] [Related]
13. Familial SDHA mutation associated with pituitary adenoma and pheochromocytoma/paraganglioma.
Dwight T; Mann K; Benn DE; Robinson BG; McKelvie P; Gill AJ; Winship I; Clifton-Bligh RJ
J Clin Endocrinol Metab; 2013 Jun; 98(6):E1103-8. PubMed ID: 23633203
[TBL] [Abstract][Full Text] [Related]
14. Pituitary adenoma associated with pheochromocytoma/paraganglioma: A new form of multiple endocrine neoplasia.
Guerrero Pérez F; Lisbona Gil A; Robledo M; Iglesias P; Villabona Artero C
Endocrinol Nutr; 2016 Nov; 63(9):506-508. PubMed ID: 27639663
[No Abstract] [Full Text] [Related]
15. SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas.
Korpershoek E; Favier J; Gaal J; Burnichon N; van Gessel B; Oudijk L; Badoual C; Gadessaud N; Venisse A; Bayley JP; van Dooren MF; de Herder WW; Tissier F; Plouin PF; van Nederveen FH; Dinjens WN; Gimenez-Roqueplo AP; de Krijger RR
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1472-6. PubMed ID: 21752896
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
